Handelsbanken Fonder
OCDX

Handelsbanken Fonder’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Handelsbanken Fonder’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,500
Closed -$401K – 1723
2022
Q1 		$401K Buy
+21,500
New +$387K ﹤0.01% 1357

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Handelsbanken Fonder's OCDX Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 21,500 shares — an estimated $401K sold.

Handelsbanken Fonder first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $401K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 21,500 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $401K.
  • Handelsbanken Fonder first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Handelsbanken Fonder's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $401K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.